Search by Drug Name or NDC
NDC 11980-0180-01 PRED FORTE 10 mg/mL Details
PRED FORTE 10 mg/mL
PRED FORTE is a OPHTHALMIC SUSPENSION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is PREDNISOLONE ACETATE.
MedlinePlus Drug Summary
Ophthalmic prednisolone reduces the irritation, redness, burning, and swelling of eye inflammation caused by chemicals, heat, radiation, infection, allergy, or foreign bodies in the eye. It sometimes is used after eye surgery. Prednisolone is in a class of medications called steroids. It prevents swelling and redness by changing the way the immune system works.
Related Packages: 11980-0180-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Prednisolone Ophthalmic
Product Information
NDC | 11980-0180 |
---|---|
Product ID | 11980-180_817efb12-c4ee-4b53-ba84-12f51626d023 |
Associated GPIs | 86300050101815 |
GCN Sequence Number | 007894 |
GCN Sequence Number Description | prednisolone acetate DROPS SUSP 1 % OPHTHALMIC |
HIC3 | Q6P |
HIC3 Description | EYE ANTI-INFLAMMATORY AGENTS |
GCN | 33153 |
HICL Sequence Number | 002870 |
HICL Sequence Number Description | PREDNISOLONE ACETATE |
Brand/Generic | Brand |
Proprietary Name | PRED FORTE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | prednisolone acetate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SUSPENSION/ DROPS |
Route | OPHTHALMIC |
Active Ingredient Strength | 10 |
Active Ingredient Units | mg/mL |
Substance Name | PREDNISOLONE ACETATE |
Labeler Name | Allergan, Inc. |
Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA017011 |
Listing Certified Through | 2024-12-31 |
Package
NDC 11980-0180-01 (11980018001)
NDC Package Code | 11980-180-01 |
---|---|
Billing NDC | 11980018001 |
Package | 1 BOTTLE, DROPPER in 1 CARTON (11980-180-01) / 1 mL in 1 BOTTLE, DROPPER |
Marketing Start Date | 1973-06-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |